Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lockhart

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Endocrinology|June 8, 2018
Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint PathobiologyKendal McCulloch, Sarah McGrath, Carmen Huesa, et al.
Journal of Medical Ethics|June 16, 2018
Development of a consensus approach for return of pathology incidental findings in the Genotype-Tissue Expression (GTEx) projectNicole C Lockhart, Carol J Weil, Latarsha J Carithers, et al.
Arthritis Research & Therapy|September 28, 2024
Small extracellular vesicles derived from synovial fibroblasts contain distinct miRNA profiles and contribute to chondrocyte damage in osteoarthritisSabha Asghar, Gary J Litherland, John J Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal AdenocarcinomaDaoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Surgery|January 16, 1999
Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2005
Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammationElizabeth B Kelso, John C Lockhart, Todd Hembrough, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancerManik Amin, Monica Desai, Kathryn Trinkaus, et al.
Surgery|June 8, 2001
Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.
International Journal of Molecular Sciences|July 2, 2021
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung DiseasesGillian A Kelly-Robinson, James A Reihill, Fionnuala T Lundy, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2006
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumorsA C Lockhart, R Bukowski, M L Rothenberg, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Endocrinology|June 8, 2018
Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint PathobiologyKendal McCulloch, Sarah McGrath, Carmen Huesa, et al.
Journal of Medical Ethics|June 16, 2018
Development of a consensus approach for return of pathology incidental findings in the Genotype-Tissue Expression (GTEx) projectNicole C Lockhart, Carol J Weil, Latarsha J Carithers, et al.
Arthritis Research & Therapy|September 28, 2024
Small extracellular vesicles derived from synovial fibroblasts contain distinct miRNA profiles and contribute to chondrocyte damage in osteoarthritisSabha Asghar, Gary J Litherland, John J Cole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal AdenocarcinomaDaoxiang Zhang, Lin Li, Hongmei Jiang, et al.
Surgery|January 16, 1999
Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2005
Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammationElizabeth B Kelso, John C Lockhart, Todd Hembrough, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancerManik Amin, Monica Desai, Kathryn Trinkaus, et al.
Surgery|June 8, 2001
Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.
International Journal of Molecular Sciences|July 2, 2021
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung DiseasesGillian A Kelly-Robinson, James A Reihill, Fionnuala T Lundy, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2006
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumorsA C Lockhart, R Bukowski, M L Rothenberg, et al.
Pageof 14